Skip to main content

Table 5 Effect of peri-operative chemotherapy on survival for metachronous synchronous CRCLM

From: Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis

 

Number of patients

3-year survival rate (%)

5-year survival rate (%)

Univariate P-value

Chemotherapy before hepatectomy

    

Present

3

33.3

0

0.2267

Absent

25

66.0

66.0

 

Chemotherapy after hepatectomy

    

Present

20

76.5

76.5

0.0458

Absent

7

0

0

Â